Under the FDA’s Rule 361, IntelliCells is authorized to commercially sell its SVF stem cells in the U.S.
In the case of IntelliCell, the company focuses more on producing large amounts of SVF cells from just a small amount of autologous fat cells of about 2 oz. IntelliCell CEO Dr. Steven Victor found a method that allows the use of ultrasonic cavitation to increase the yield of SVF cells. By using the ultrasonic method, Dr. Victor says he turns the 2 oz. of fat into SVF stem cells of between 0.5 billion and 1.4 billion. The process takes just about 30 minutes at IntelliCell’s labs. Doctors then use the SVF cells for treatment of various ailments, from regenerative cosmetic procedures to repairing tissues involving damaged knees, back injuries, migraine headaches, and multiple sclerosis.
“It is very apparent that a person’s fat cells are the best source of stem cells, which are stored inactively in one’s fat tissues, for use in the fast growing field of regenerative medicine,” says Dr. Victor, a practicing dermatologist for more than 20 years. He says IntelliCell’s proprietary process makes the most cells from the least amount of fat more efficiently and less expensive than any other competing products.
A study of IntelliCell’s technology by Millipore, a division of Merck AG of Germany, confirmed that it produced an average of 10 times the number of SVF cells containing adult adipose stem cells from less than which the company believes is used by any of its present competition that use enzymes in their process. The study also showed that the SVF cells produced by IntelliCell contain all of the viable cells that are manufactured by competing technologies that use enzymes, such as Cytori.